A new essay examines how Chemical Reaction Network Theory (CRNT) offers a way to study complex biochemical systems without relying on huge numbers of hard-to-estimate rate constants. Drawing on Martin Feinberg's foundational work, it argues that qualitative, structural models can predict how chemical systems behave even when precise parameters are unknown. The piece frames this as a step toward understanding life-like chemical processes and eventually engineering synthetic systems with similar robustness.
chillphysicsenjoyer.substack.com
· 2026-11-16
Biochemist Klára Hlouchová's team reported in recent studies that proteins built from just 10 amino acids can form the same robust folds seen in modern life, suggesting early organisms may have used a simpler molecular toolkit. She is now testing whether entirely different sets of amino acids can achieve similar results, while other origin-of-life researchers debate how closely such experiments should model existing biology.
quantamagazine.org
· 2026-11-13
Scientists reported designing new enzymes capable of cleaving peptide bonds using an activated cysteine nucleophile, achieving success in 13 of 69 designs. The engineered proteases, whose structures differ substantially from natural proteases, accelerated the cutting reaction by up to 30 million times over background rates, and six crystal structures closely matched computational design models. The enzymes also functioned effectively when tested inside mammalian cells.
nature.com
· 2026-10-14
Samuel King, a bioengineering PhD candidate at Stanford, employed a generative AI model in 2025 to create genetic blueprints for microscopic viruses. His work suggests that AI could potentially be used to design new biological entities in the future. The interview with senior AI reporter James O'Donnell will explore the implications of this research for biology and AI development.
technologyreview.com
· 2026-10-09
MIT Technology Review's newsletters explore how AI tools could be misused to create bioweapons, citing a 2022 study where an AI drug-discovery model generated 40,000 potentially toxic molecules in under six hours. The coverage also notes that advances in gene editing and synthetic biology have made biotech more accessible, even as safeguards remain imperfect.
technologyreview.com
· 2026-09-18
TechCrunch Disrupt 2026, running October 13-15 in San Francisco, will host a fireside chat titled 'Can We Engineer Nature's Comeback?' featuring Ben Lamm, co-founder and CEO of Colossal Biosciences. The session will examine how AI and synthetic biology are being used to attempt reviving extinct species and what that means for conservation efforts.
techcrunch.com
· 2026-09-14
Researchers have devised a method to operate two separate genetic codes at once without needing to re-engineer an organism's entire genome to accommodate the change. The approach was tested outside living cells, so it avoids the laborious process of altering every gene, as previous efforts required when adding new amino acids to bacterial proteins.
arstechnica.com
· 2026-08-26